163 related articles for article (PubMed ID: 8176379)
1. Difference in neutralization between lactate dehydrogenase-elevating virus isolated from acutely and chronically infected mice.
Monteyne P; Coutelier JP
J Gen Virol; 1994 May; 75 ( Pt 5)():1173-6. PubMed ID: 8176379
[TBL] [Abstract][Full Text] [Related]
2. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation.
Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG
J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369
[TBL] [Abstract][Full Text] [Related]
3. Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus.
Plagemann PG
Virology; 2001 Nov; 290(1):11-20. PubMed ID: 11882995
[TBL] [Abstract][Full Text] [Related]
4. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein.
Chen Z; Li K; Plagemann PG
Virology; 2000 Jan; 266(1):88-98. PubMed ID: 10612663
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid regulation of lactate dehydrogenase-elevating virus replication in macrophages.
Cafruny WA; Jones QA; Haven TR; Zitterkopf NL; Plagemann PG; Rowland RR
Virus Res; 2003 Mar; 92(1):83-7. PubMed ID: 12606079
[TBL] [Abstract][Full Text] [Related]
6. Neutralization and sensitization of lactate dehydrogenase-elevating virus with monoclonal antibodies.
Coutelier JP; Van Snick J
J Gen Virol; 1988 Aug; 69 ( Pt 8)():2097-100. PubMed ID: 3404124
[TBL] [Abstract][Full Text] [Related]
7. Trojan Horse macrophages: studies with the murine lactate dehydrogenase-elevating virus and implications for sexually transmitted virus infection.
Cafruny WA; Bradley SE
J Gen Virol; 1996 Dec; 77 ( Pt 12)():3005-12. PubMed ID: 9000091
[TBL] [Abstract][Full Text] [Related]
8. Regulation of immune complexes during infection of mice with lactate dehydrogenase-elevating virus: studies with interferon-gamma gene knockout and tolerant mice.
Cafruny WA; Bradley SE; Rowland RR
Viral Immunol; 1999; 12(2):163-73. PubMed ID: 10413362
[TBL] [Abstract][Full Text] [Related]
9. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies.
Weiland E; Weiland F; Grossmann A
J Gen Virol; 1987 Jul; 68 ( Pt 7)():1983-91. PubMed ID: 3598563
[TBL] [Abstract][Full Text] [Related]
10. Transplacental lactate dehydrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression.
Zitterkopf NL; Haven TR; Huela M; Bradley DS; Cafruny WA
Placenta; 2002 May; 23(5):438-46. PubMed ID: 12061860
[TBL] [Abstract][Full Text] [Related]
11. Protection of C58 mice from lactate dehydrogenase-elevating virus-induced motor neuron disease by non-neutralizing antiviral antibodies without interference with virus replication.
Harty JT; Chan SP; Contag CH; Plagemann PG
J Neuroimmunol; 1987 Jun; 15(2):195-206. PubMed ID: 3034974
[TBL] [Abstract][Full Text] [Related]
12. The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein.
Li K; Chen Z; Plagemann P
Virology; 1998 Mar; 242(2):239-45. PubMed ID: 9514969
[TBL] [Abstract][Full Text] [Related]
13. Mode of neutralization of lactate dehydrogenase-elevating virus by polyclonal and monoclonal antibodies.
Plagemann PG; Harty JT; Even C
Arch Virol; 1992; 123(1-2):89-100. PubMed ID: 1372497
[TBL] [Abstract][Full Text] [Related]
14. Immune response to lactate dehydrogenase-elevating virus: serologically specific rabbit neutralizing antibody to the virus.
Cafruny WA; Plagemann PG
Infect Immun; 1982 Sep; 37(3):1007-12. PubMed ID: 7129627
[TBL] [Abstract][Full Text] [Related]
15. Replication of lactate dehydrogenase-elevating virus in C58 mice and quantification of antiviral antibodies and of tissue virus levels as a function of development of paralytic disease.
Cafruny WA; Strancke CR; Kowalchyk K; Plagemann PG
J Gen Virol; 1986 Jan; 67 ( Pt 1)():27-37. PubMed ID: 3944584
[TBL] [Abstract][Full Text] [Related]
16. Changes in antibody specificities and cytokine release after infection with lactate dehydrogenase-elevating virus.
Aparicio JL; Saxena A; Coutelier JP; Van Snick J; Retegui LA
Int Immunopharmacol; 2013 Mar; 15(3):544-9. PubMed ID: 23391715
[TBL] [Abstract][Full Text] [Related]
17. Formalin inactivation of the lactate dehydrogenase-elevating virus reveals a major neutralizing epitope not recognized during natural infection.
Harty JT; Plagemann PG
J Virol; 1988 Sep; 62(9):3210-6. PubMed ID: 2457113
[TBL] [Abstract][Full Text] [Related]
18. Changes in the specificity of antibodies in mice infected with lactate dehydrogenase-elevating virus.
Gómez KA; Coutelier JP; Retegui LA
Scand J Immunol; 1997 Aug; 46(2):168-74. PubMed ID: 9583997
[TBL] [Abstract][Full Text] [Related]
19. Divergent roles of IFNs in the sensitization to endotoxin shock by lactate dehydrogenase-elevating virus.
Le-Thi-Phuong T; Dumoutier L; Renauld JC; Van Snick J; Coutelier JP
Int Immunol; 2007 Nov; 19(11):1303-11. PubMed ID: 17914119
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to cryptic epitopes elicited by infection with lactate dehydrogenase-elevating virus.
Gómez KA; Coutelier J; Mathieu PA; Lustig L; Retegui LA
Scand J Immunol; 2000 May; 51(5):447-53. PubMed ID: 10792835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
